Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.
Category: Covered California
KHN’s ‘What the Health?’: A Conversation With Peter Lee on What’s Next for the ACA
Amid covid-19, the potential overturn of Roe v. Wade, and a war in Europe, the Affordable Care Act has been flying under the radar in 2022. But this will be a pivotal year for the federal health law. Unless Congress acts, millions of Americans could see their costs for coverage rise dramatically as expanded subsidies expire. At the same time, the end of the public health emergency could boost the uninsured rate as states disenroll people from Medicaid. Peter Lee, who recently stepped down as the first executive director of the largest state-run ACA insurance marketplace, Covered California, has thought long and hard about how the ACA came to be, how it’s been implemented, and what should happen to it now. He joins host and KHN chief Washington correspondent Julie Rovner for a wide-ranging discussion on the state of the ACA.
Don’t Count on Lower Premiums Despite Pandemic-Driven Boon for Insurers
Early in the pandemic, insurers expected the costs of treating COVID-19 would vastly increase medical spending. Instead, non-COVID care has plummeted and insurers have pocketed the result. Still, few industry observers are predicting broad-based premium cuts in 2021, though some health plans have proposed lowering their rates.